Laura Melado Vidales: Integrating High-Specific Assays for Anti-Müllerian Hormone with Antral Follicle Count
Laura Melado Vidales, Medical Director at ART Fertility Clinics Abu Dhabi, shared a post on LinkedIn about a paper published in Frontiers:
“Excited to share that our new paper is out in Frontiers in Endocrinology!
‘How to enhance prediction of clinical outcomes in poor responders: integrating high-specific assays for anti-Müllerian hormone with antral follicle count.’
Read here.
We show that combining high-specific AMH assays with antral follicle count (AFC) improves the prediction of ovarian response in women with low ovarian reserve, supporting more personalized fertility care.
Grateful to my co-authors and colleagues for this great collaboration!”
Title: How to enhance prediction of clinical outcomes in poor responders: integrating high-specific assays for anti-mullerian hormone with antral follicle count
Authors: Laura Melado, Ajay Kumar, Bhanu Kalra, Erkan Kalafat, Barbara Lawrenz, Human Fatemi
-
Apr 15, 2026, 16:38Why an Ovulation Trigger Shot Sometimes Fails – Fertility Plus
-
Apr 15, 2026, 16:3374 New Studies Added to the AC Forum Literature Library – Anticoagulation Forum
-
Apr 15, 2026, 16:23Insights from PGT-A in Recurrent IVF Failure – Motherhood Training Center
-
Apr 15, 2026, 16:20Effect of Endometriosis and Adenomyosis on Oocyte Quality and Morphology – RBMO
-
Apr 15, 2026, 11:37Ally Murji: Honoured to be Part of the Canadian Session at the SEUD Meeting
-
Apr 15, 2026, 11:00Scammers are Targeting ESHRE2026 Attendees With Fake Registration and Hotel Offers – ESHRE
-
Apr 15, 2026, 10:24Join Us This Friday for Our “Research in Progress” – SRF
-
Apr 15, 2026, 10:20The Importance of Fertility Preservation in Turner Syndrome – RBMO
-
Apr 15, 2026, 10:16Marlena Fejzo: Our Study Identifying 6 New Genes Associated with Hyperemesis Gravidarum